DENTSPLY SIRONA (XRAY) Stock Forecast, Price Target & Predictions
XRAY Stock Forecast
DENTSPLY SIRONA stock forecast is as follows: an average price target of $20.00 (represents a 1.88% upside from XRAY’s last price of $19.63) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.
XRAY Price Target
The average price target for DENTSPLY SIRONA (XRAY) is $20.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $20.00. This represents a potential 1.88% upside from XRAY's last price of $19.63.
XRAY Analyst Ratings
According to 6 Wall Street analysts, DENTSPLY SIRONA's rating consensus is 'Hold'. The analyst rating breakdown for XRAY stock is 0 'Strong Buy' (0.00%), 2 'Buy' (33.33%), 4 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
DENTSPLY SIRONA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 23, 2025 | Glen Santangelo | Jefferies | $20.00 | $19.36 | 3.31% | 1.88% |
| Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $31.00 | $26.36 | 17.60% | 57.92% |
| Jul 18, 2024 | Jonathan Block | Stifel Nicolaus | $28.00 | $27.54 | 1.67% | 42.64% |
| May 03, 2024 | Jason Bednar | Piper Sandler | $32.00 | $28.13 | 13.76% | 63.02% |
| Nov 16, 2023 | David Saxon | Needham | $35.00 | $29.61 | 18.18% | 78.30% |
| Jun 01, 2022 | Kevin Caliendo | UBS | $47.00 | $39.04 | 20.39% | 139.43% |
| Apr 22, 2022 | H.C. Wainwright | $48.00 | $42.09 | 14.04% | 144.52% | |
| Apr 21, 2022 | Goldman Sachs | $47.00 | $42.89 | 9.58% | 139.43% | |
| Apr 20, 2022 | Morgan Stanley | $52.00 | $42.89 | 21.24% | 164.90% | |
| Apr 20, 2022 | Piper Sandler | $46.00 | $42.20 | 9.00% | 134.34% | |
| Apr 19, 2022 | Jeffrey Johnson | Robert W. Baird | $48.00 | $42.63 | 12.60% | 144.52% |
| Nov 04, 2021 | Jonathan Block | Stifel Nicolaus | $60.00 | $54.69 | 9.71% | 205.65% |
| Aug 06, 2021 | Jason Bednar | Piper Sandler | $75.00 | $59.91 | 25.19% | 282.07% |
The latest DENTSPLY SIRONA stock forecast, released on Jan 23, 2025 by Glen Santangelo from Jefferies, set a price target of $20.00, which represents a 3.31% increase from the stock price at the time of the forecast ($19.36), and a 1.88% increase from XRAY last price ($19.63).
DENTSPLY SIRONA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 4 |
| Avg Price Target | $20.00 | $20.00 | $27.75 |
| Last Closing Price | $19.63 | $19.63 | $19.63 |
| Upside/Downside | 1.88% | 1.88% | 41.37% |
In the current month, the average price target of DENTSPLY SIRONA stock is $20.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 1.88% increase as opposed to DENTSPLY SIRONA's last price of $19.63. This month's average price target is down 0.00% compared to last quarter, and down -27.93% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jan 23, 2025 | Jefferies | Hold | Downgrade | |
| Oct 08, 2024 | Evercore ISI | Underperform | Underperform | Hold |
| Sep 27, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Sep 20, 2024 | Needham | Buy | Buy | Hold |
| Aug 20, 2024 | Needham | Buy | Buy | Hold |
| Aug 20, 2024 | Evercore Partners | Underperform | Underperform | Hold |
| Jul 18, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jul 18, 2024 | Needham | Underperform | Underperform | Hold |
| Jun 25, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 06, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 03, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Apr 18, 2024 | Needham | Buy | Buy | Hold |
| Apr 18, 2024 | Leerink Partners | Underperform | Underperform | Hold |
| Feb 29, 2024 | Needham | Underperform | Underperform | Hold |
| Feb 29, 2024 | Piper Sandler | Buy | Buy | Hold |
| Nov 16, 2023 | Needham | Buy | Initialise | |
| Aug 03, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Feb 28, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Jan 11, 2023 | William Blair | Market Perform | Upgrade | |
| Jan 11, 2023 | Piper Sandler | Neutral | Neutral | Hold |
| Jun 01, 2022 | UBS | Buy | Upgrade | |
| May 12, 2022 | Deutsche Bank | Hold | Hold | Hold |
DENTSPLY SIRONA's last stock rating was published by Jefferies on Jan 23, 2025. The company Downgrade its XRAY rating from "null" to "Hold".
DENTSPLY SIRONA Financial Forecast
DENTSPLY SIRONA Revenue Forecast
| Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $947.00M | $1.03B | $978.00M | $983.00M | $947.00M | $1.02B | $965.00M | $1.09B | $1.07B | $1.07B |
| Avg Forecast | $984.73M | $982.59M | $980.45M | $978.32M | $976.19M | $974.06M | $971.94M | $969.63M | $941.60M | $981.57M | $933.89M | $943.66M | $919.43M | $959.31M | $914.15M | $921.28M | $939.10M | $993.61M | $969.45M | $971.51M | $975.21M | $998.98M | $937.70M | $941.92M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B |
| High Forecast | $1.01B | $1.01B | $1.01B | $1.01B | $1.01B | $1.00B | $1.00B | $998.78M | $969.91M | $1.01B | $961.97M | $972.04M | $947.07M | $988.15M | $949.91M | $932.94M | $939.87M | $993.61M | $969.45M | $994.25M | $975.31M | $1.03B | $965.90M | $964.72M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B |
| Low Forecast | $958.23M | $956.15M | $954.07M | $951.99M | $949.92M | $947.85M | $945.79M | $943.54M | $916.26M | $955.15M | $908.76M | $918.27M | $894.69M | $933.49M | $897.81M | $908.47M | $938.32M | $993.61M | $969.45M | $951.41M | $975.12M | $972.10M | $912.47M | $920.28M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B |
| # Analysts | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 1.03% | 1.04% | 1.04% | 0.94% | 1.01% | 0.97% | 0.96% | 1.04% | 1.05% |
DENTSPLY SIRONA's average Quarter revenue forecast for Dec 23 based on 10 analysts is $971.51M, with a low forecast of $951.41M, and a high forecast of $994.25M. XRAY's average Quarter revenue forecast represents a 2.59% increase compared to the company's last Quarter revenue of $947.00M (Sep 23).
DENTSPLY SIRONA EBITDA Forecast
| Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $77.00M | $158.00M | $138.00M | $34.00M | $142.00M | $197.00M | $182.00M | $235.00M | $239.00M | $243.00M |
| Avg Forecast | $76.90M | $76.73M | $76.56M | $76.40M | $76.23M | $76.07M | $75.90M | $75.72M | $73.53M | $76.65M | $72.93M | $73.69M | $71.80M | $74.91M | $71.39M | $71.94M | $73.34M | $77.59M | $207.93M | $75.87M | $76.16M | $78.01M | $189.02M | $268.32M | $202.46M | $203.27M | $171.84M | $226.80M | $205.94M | $203.37M |
| High Forecast | $79.21M | $79.04M | $78.87M | $78.70M | $78.52M | $78.35M | $78.18M | $78.00M | $75.74M | $78.96M | $75.12M | $75.91M | $73.96M | $77.17M | $74.18M | $72.85M | $73.40M | $77.59M | $249.51M | $77.64M | $76.16M | $80.36M | $226.83M | $321.98M | $202.46M | $203.27M | $206.21M | $226.80M | $205.94M | $203.37M |
| Low Forecast | $74.83M | $74.67M | $74.50M | $74.34M | $74.18M | $74.02M | $73.86M | $73.68M | $71.55M | $74.59M | $70.97M | $71.71M | $69.87M | $72.90M | $70.11M | $70.94M | $73.27M | $77.59M | $166.34M | $74.30M | $76.15M | $75.91M | $151.22M | $214.65M | $202.46M | $203.27M | $137.47M | $226.80M | $205.94M | $203.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 2.03% | 0.73% | 0.13% | 0.70% | 0.97% | 1.06% | 1.04% | 1.16% | 1.19% |
10 analysts predict XRAY's average Quarter EBITDA for Dec 23 to be $75.87M, with a high of $77.64M and a low of $74.30M. This is -1.47% lower than DENTSPLY SIRONA's previous annual EBITDA (Sep 23) of $77.00M.
DENTSPLY SIRONA Net Income Forecast
| Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-266.00M | $86.00M | $-23.00M | $-15.00M | $-1.08B | $73.00M | $65.00M | $102.00M | $103.00M | $99.00M |
| Avg Forecast | $101.42M | $108.45M | $78.51M | $83.61M | $94.43M | $99.11M | $86.87M | $108.75M | $109.57M | $111.05M | $95.76M | $102.92M | $99.32M | $99.46M | $83.54M | $86.26M | $95.36M | $99.76M | $75.50M | $87.04M | $97.25M | $86.80M | $68.64M | $116.46M | $107.40M | $112.72M | $62.40M | $161.99M | $133.50M | $136.62M |
| High Forecast | $105.38M | $112.68M | $81.58M | $86.87M | $98.12M | $102.98M | $90.27M | $113.00M | $113.86M | $115.39M | $99.50M | $106.94M | $103.20M | $103.35M | $101.88M | $90.27M | $95.62M | $99.79M | $90.60M | $93.11M | $97.27M | $90.19M | $82.37M | $139.75M | $107.40M | $112.72M | $74.88M | $161.99M | $133.50M | $136.62M |
| Low Forecast | $97.87M | $104.65M | $75.76M | $80.68M | $91.13M | $95.64M | $83.84M | $104.94M | $105.74M | $107.17M | $92.41M | $99.32M | $95.84M | $95.98M | $77.43M | $82.25M | $95.10M | $99.73M | $60.40M | $85.01M | $97.24M | $83.76M | $54.91M | $93.17M | $107.40M | $112.72M | $49.92M | $161.99M | $133.50M | $136.62M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.74% | 0.99% | -0.34% | -0.13% | -10.03% | 0.65% | 1.04% | 0.63% | 0.77% | 0.72% |
DENTSPLY SIRONA's average Quarter net income forecast for Sep 23 is $97.25M, with a range of $97.24M to $97.27M. XRAY's average Quarter net income forecast represents a 13.09% increase compared to the company's last Quarter net income of $86.00M (Jun 23).
DENTSPLY SIRONA SG&A Forecast
| Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $372.00M | $416.00M | $416.00M | $402.00M | $401.00M | $410.00M | $374.00M | $374.00M | $394.00M | $398.00M |
| Avg Forecast | $400.93M | $400.05M | $399.18M | $398.32M | $397.45M | $396.58M | $395.72M | $394.78M | $383.36M | $399.64M | $380.23M | $384.21M | $374.34M | $390.58M | $372.19M | $375.09M | $382.35M | $404.54M | $434.44M | $395.54M | $397.05M | $406.73M | $394.94M | $427.02M | $409.84M | $411.47M | $359.04M | $459.11M | $416.89M | $411.67M |
| High Forecast | $412.98M | $412.08M | $411.19M | $410.29M | $409.40M | $408.51M | $407.62M | $406.65M | $394.89M | $411.66M | $391.66M | $395.76M | $385.59M | $402.32M | $386.75M | $379.84M | $382.66M | $404.54M | $521.33M | $404.80M | $397.09M | $418.96M | $473.93M | $512.43M | $409.84M | $411.47M | $430.85M | $459.11M | $416.89M | $411.67M |
| Low Forecast | $390.14M | $389.29M | $388.44M | $387.60M | $386.75M | $385.91M | $385.07M | $384.15M | $373.05M | $388.88M | $369.99M | $373.87M | $364.27M | $380.07M | $365.54M | $369.88M | $382.03M | $404.54M | $347.55M | $387.36M | $397.01M | $395.78M | $315.96M | $341.62M | $409.84M | $411.47M | $287.23M | $459.11M | $416.89M | $411.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.02% | 1.05% | 0.94% | 0.98% | 1.00% | 1.04% | 0.81% | 0.95% | 0.97% |
DENTSPLY SIRONA's average Quarter SG&A projection for Dec 23 is $395.54M, based on 10 Wall Street analysts, with a range of $387.36M to $404.80M. The forecast indicates a 6.33% rise compared to XRAY last annual SG&A of $372.00M (Sep 23).
DENTSPLY SIRONA EPS Forecast
| Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.26 | $0.41 | $-0.11 | $-0.07 | $-5.01 | $0.34 | $0.32 | $0.47 | $0.47 | $0.45 |
| Avg Forecast | $0.50 | $0.54 | $0.39 | $0.42 | $0.47 | $0.49 | $0.43 | $0.54 | $0.55 | $0.55 | $0.48 | $0.51 | $0.49 | $0.49 | $0.42 | $0.43 | $0.47 | $0.50 | $0.42 | $0.43 | $0.48 | $0.43 | $0.34 | $0.33 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 |
| High Forecast | $0.52 | $0.56 | $0.41 | $0.43 | $0.49 | $0.51 | $0.45 | $0.56 | $0.57 | $0.57 | $0.50 | $0.53 | $0.51 | $0.51 | $0.51 | $0.45 | $0.48 | $0.50 | $0.42 | $0.46 | $0.48 | $0.45 | $0.35 | $0.34 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 |
| Low Forecast | $0.49 | $0.52 | $0.38 | $0.40 | $0.45 | $0.48 | $0.42 | $0.52 | $0.53 | $0.53 | $0.46 | $0.49 | $0.48 | $0.48 | $0.39 | $0.41 | $0.47 | $0.50 | $0.42 | $0.42 | $0.48 | $0.42 | $0.33 | $0.32 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.60% | 0.95% | -0.32% | -0.21% | -9.59% | 0.62% | 0.57% | 0.60% | 0.72% | 0.68% |
According to 9 Wall Street analysts, DENTSPLY SIRONA's projected average Quarter EPS for Sep 23 is $0.48, with a low estimate of $0.48 and a high estimate of $0.48. This represents a 18.01% increase compared to XRAY previous annual EPS of $0.41 (Jun 23).
DENTSPLY SIRONA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $98.00 | $250.86 | 155.98% | Buy |
| HAE | Haemonetics | $68.29 | $107.00 | 56.68% | Buy |
| TFX | Teleflex | $180.58 | $257.67 | 42.69% | Buy |
| HOLX | Hologic | $71.41 | $87.33 | 22.29% | Buy |
| ALC | Alcon | $91.38 | $107.80 | 17.97% | Buy |
| WST | West Pharmaceutical Services | $339.57 | $393.00 | 15.73% | Buy |
| ICUI | ICU Medical | $168.30 | $190.50 | 13.19% | Buy |
| BDX | Becton, Dickinson and | $246.90 | $278.75 | 12.90% | Buy |
| ANGO | AngioDynamics | $12.46 | $13.00 | 4.33% | Buy |
| XRAY | DENTSPLY SIRONA | $19.63 | $20.00 | 1.88% | Hold |
| MMSI | Merit Medical Systems | $108.48 | $105.60 | -2.65% | Buy |
| RMD | ResMed | $252.86 | $233.50 | -7.66% | Hold |